Insider Trading
SMTI Stock | USD 37.70 0.38 1.02% |
Under 51% of Sanara Medtech's traders are presently thinking to get in. The analysis of overall sentiment of trading Sanara Medtech stock suggests that some investors are interested at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
Sanara |
Filed transaction by Sanara Medtech Officer. Insider Public Trading
Read at macroaxis.com
Sanara Medtech Fundamental Analysis
We analyze Sanara Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanara Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanara Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Sanara Medtech is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Sanara Medtech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
Peers
Sanara Medtech Related Equities
DXR | Daxor | 6.57 | ||||
PDEX | Pro Dex | 4.81 | ||||
KRMD | Repro Med | 3.98 | ||||
HAE | Haemonetics | 3.40 | ||||
NVST | Envista Holdings | 3.26 | ||||
MLSS | Milestone Scientific | 2.60 | ||||
ANGO | AngioDynamics | 2.34 | ||||
UTMD | Utah Medical | 1.04 | ||||
ATR | AptarGroup | 0.58 | ||||
MMSI | Merit Medical | 0.39 | ||||
POCI | Precision Optics, | 0.59 | ||||
LMAT | LeMaitre Vascular | 0.82 | ||||
INFU | InfuSystems Holdings | 0.86 | ||||
MHUA | Meihua International | 18.06 |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |